Latest Articles

5 Tips for Dealing with Rheumatoid Arthritis Pain
Do you suffer from rheumatoid arthritis and have had to quit taking your prescription pain medication because of harmful side effects? Are you looking for natural alternatives to help you deal with the pain that you face doing everyday tasks? If...

No Pain, No Gain Isn't True For Arthritis, But Exercise Is Still Important
Recent studies have shown that exercise may acually help people with arthritis in a number of ways. It can reduce joint pain and stiffness. It can increase flexibility, muscle strength, and endurance. And it can also help with weight reduction and...

Searching for Osteoarthritis Pain Relief?
Copyright 2006 Kristy Haugen Osteoarthritis or degenerative joint disease is a wear and tear disease of the joints typically seen in the older adult (usually over 60 years of age). Cartilage within the joints breaks down causing pain as the...

"My Doctor Wants Me to Take Enbrel For My Rheumatoid Arthritis-What Can You Tell me About it?

TNF alpha is a cytokine, a protein that is produced during the inflammatory response. TNF alpha is involved in inflammation from two perspectives. It is not only the product of inflammation; it also helps perpetuate and promote inflammation. Increased levels of TNF are found in several inflammatory conditions including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Drugs that block tumor necrosis factor (TNF) have been found to be particularly effective for the treatment of these serious forms of inflammatory arthritis.

The first anti-TNF drug approved for such use was etanercept (Enbrel).

Etanercept is a synthetic (man-made) protein that binds to TNF alpha. It acts like a sponge to remove most of the TNF alpha molecules from the joints and blood. This prevents TNF alpha from perpetuating inflammation and the pain, tenderness and swelling of joints in patients with different types of arthritis.

Etanercept reduces the signs and symptoms of rheumatoid arthritis, the arthritis of psoriasis, and ankylosing spondylitis. It also prevents the progression of joint destruction in patients with rheumatoid arthritis and the arthritis of psoriasis.

Etanercept is usually used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.

Etanercept comes in two different preparations. The first is a powder that must be reconstituted (mixed) with a diluent. This comes as a 25 mg dose. The second is as a premixed syringe containing 50 mgs of etanercept. Etanercept must be refrigerated. The drug is given as a subcutaneous injection. Dosing will vary according to disease severity and body size.

Because etanercept reduces the immune response, it should not be administered with live vaccines. Etanercept is not recommended for use in pregnant or nursing women.

The most

common side effects are mild to moderate itching, pain, swelling and redness at the site of injection. Headache, dizziness, nose and throat irritation also occur.

TNF alpha has an important role in the response of the immune system to infections. Blocking the action of TNF alpha with etanercept may worsen or increase the occurrence of infections, and patients with serious infections should not receive etanercept. Etanercept should be discontinued if a patient develops a serious infection. It should not be given to patients with active infections or who have an allergy to its components. Etanercept should be used with caution in patients prone to infection, such as those with poorly controlled diabetes.

Since etanercept has entered the market, there have been reports of multiple sclerosis, myelitis, optic neuritis in patients using the drug. Etanercept is not recommended for persons with preexisting disease of the central nervous system (brain and/or spinal cord) or for those with multiple sclerosis, myelitis, or optic neuritis. Rare cases of potentially serious low blood counts (pancytopenia) have been reported in patients using etanercept.

Monitoring should be done according to guidelines set by the rheumatologist.

Dr. Wei (pronounced “way”) is a board-certified rheumatologist and Clinical Director of the nationally respected Arthritis and Osteoporosis Center of Maryland. He is a Clinical Assistant Professor of Medicine at the University of Maryland School of Medicine and has served as a consultant to the Arthritis Branch of the National Institutes of Health. He is a Fellow of the American College of Rheumatology and the American College of Physicians. For more information on arthritis and related conditions, go to: http://www.arthritis-treatment-and-relief.com


Written By: Nathan Wei


People's Pharmacy: Supplement for arthritis raised cholesterol - Tuscaloosa News
studies do not demonstrate any benefits for mild to moderate ... My 15-year-old son had low HDL and a poor cholesterol profile at his checkup. (Total cholesterol was 146, HDL 29 and LDL 96). So for 10 months,

Rheumatoid Arthritis Signaling Protein GM-CSF Reverses Alzheimer's Disease In Mouse ... - Medical News Today
A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer's disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease ...

Disease Activity Is Main Factor in Disability from Rheumatoid Arthritis - Newswise
Source: Wolters Kluwer Health: Lippincott Williams & Wilkins Newswise — For people living with rheumatoid arthritis (RA), the level of disease activity—measured using the standard DAS 28 score—is the factor most ...

Chelsea Therapeutics' experimental rheumatoid arthritis drug trial gets FDA nod - Small Cap Network
As we told our readers last Friday, Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) was set to run higher in anticipation of FDA news. This morning, the company has announced that the U.S. Food and ...

Chelsea Therapeutics gets FDA OK to start study - Forbes
CHARLOTTE, N.C. -- Chelsea Therapeutics International Ltd. said Thursday it received Food and Drug Administration clearance to start a midstage study on a potential rheumatoid arthritis drug. The company said ...

Celebrex Appears Easier on Stomach for Arthritis Patients - MedicineNet.com
THURSDAY, June 17 (HealthDay News) -- Patients who take the painkiller celecoxib for arthritis pain and inflammation are less likely to suffer gastrointestinal damage than those who take diclofenac plus omeprazole , a ...

Arthritis: The Secret to Treating Alzheimer's? - Redorbit.com
(Ivanhoe Newswire) -- Researchers know that people with rheumatoid arthritis are less likely to develop Alzheimer's disease. Now, they may have an explanation why. A new study shows a protein released in ...

Sign up for PayPal and start accepting credit card payments instantly.